Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive Model.

Grabb MC, Cross AJ, Potter WZ, McCracken JT.

J Clin Psychopharmacol. 2016 Oct;36(5):419-21. doi: 10.1097/JCP.0000000000000536. No abstract available.

PMID:
27404513
2.

DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond.

Markkanen E, Meyer U, Dianov GL.

Int J Mol Sci. 2016 Jun 1;17(6). pii: E856. doi: 10.3390/ijms17060856. Review.

3.

DNA Methylation Profiling at Single-Base Resolution Reveals Gestational Folic Acid Supplementation Influences the Epigenome of Mouse Offspring Cerebellum.

Barua S, Kuizon S, Brown WT, Junaid MA.

Front Neurosci. 2016 May 3;10:168. doi: 10.3389/fnins.2016.00168. eCollection 2016.

4.

Autistic-Like Behaviors, Oxidative Stress Status, and Histopathological Changes in Cerebellum of Valproic Acid Rat Model of Autism Are Improved by the Combined Extract of Purple Rice and Silkworm Pupae.

Morakotsriwan N, Wattanathorn J, Kirisattayakul W, Chaisiwamongkol K.

Oxid Med Cell Longev. 2016;2016:3206561. doi: 10.1155/2016/3206561. Epub 2016 Jan 4.

5.

Insulin-Independent GABAA Receptor-Mediated Response in the Barrel Cortex of Mice with Impaired Met Activity.

Lo FS, Erzurumlu RS, Powell EM.

J Neurosci. 2016 Mar 30;36(13):3691-7. doi: 10.1523/JNEUROSCI.0006-16.2016.

PMID:
27030755
6.

From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders.

Romano A, Tempesta B, Micioni Di Bonaventura MV, Gaetani S.

Front Neurosci. 2016 Jan 12;9:497. doi: 10.3389/fnins.2015.00497. eCollection 2015. Review.

7.

Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex.

Labouesse MA, Dong E, Grayson DR, Guidotti A, Meyer U.

Epigenetics. 2015;10(12):1143-55. doi: 10.1080/15592294.2015.1114202.

PMID:
26575259
8.

Inhibition-Based Biomarkers for Autism Spectrum Disorder.

Levin AR, Nelson CA.

Neurotherapeutics. 2015 Jul;12(3):546-52. doi: 10.1007/s13311-015-0350-1. Review.

9.

GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism.

Silverman JL, Pride MC, Hayes JE, Puhger KR, Butler-Struben HM, Baker S, Crawley JN.

Neuropsychopharmacology. 2015 Aug;40(9):2228-39. doi: 10.1038/npp.2015.66. Epub 2015 Mar 10.

10.

Behavioral training reverses global cortical network dysfunction induced by perinatal antidepressant exposure.

Zhou X, Lu JY, Darling RD, Simpson KL, Zhu X, Wang F, Yu L, Sun X, Merzenich MM, Lin RC.

Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2233-8. doi: 10.1073/pnas.1416582111. Epub 2015 Feb 2.

11.

Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH₃ in an immune-mediated neurodevelopmental disruption model.

Richetto J, Labouesse MA, Poe MM, Cook JM, Grace AA, Riva MA, Meyer U.

Int J Neuropsychopharmacol. 2015 Jan 30;18(4). pii: pyu055. doi: 10.1093/ijnp/pyu055.

12.

Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.

Berretta S, Heckers S, Benes FM.

Schizophr Res. 2015 Sep;167(1-3):91-7. doi: 10.1016/j.schres.2014.10.019. Epub 2014 Nov 11. Review.

13.

Epigenetic mechanisms in schizophrenia.

Akbarian S.

Dialogues Clin Neurosci. 2014 Sep;16(3):405-17. Review.

14.

Modulation of corticospinal excitability by transcranial magnetic stimulation in children and adolescents with autism spectrum disorder.

Oberman LM, Pascual-Leone A, Rotenberg A.

Front Hum Neurosci. 2014 Aug 13;8:627. doi: 10.3389/fnhum.2014.00627. eCollection 2014.

15.

Biomarkers in autism.

Goldani AA, Downs SR, Widjaja F, Lawton B, Hendren RL.

Front Psychiatry. 2014 Aug 12;5:100. doi: 10.3389/fpsyt.2014.00100. eCollection 2014. Review.

16.

Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission.

Karayannis T, Au E, Patel JC, Kruglikov I, Markx S, Delorme R, Héron D, Salomon D, Glessner J, Restituito S, Gordon A, Rodriguez-Murillo L, Roy NC, Gogos JA, Rudy B, Rice ME, Karayiorgou M, Hakonarson H, Keren B, Huguet G, Bourgeron T, Hoeffer C, Tsien RW, Peles E, Fishell G.

Nature. 2014 Jul 10;511(7508):236-40.

17.

Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum.

Edmonson C, Ziats MN, Rennert OM.

Mol Autism. 2014 Jan 10;5(1):3. doi: 10.1186/2040-2392-5-3.

18.

Association of social and cognitive impairment and biomarkers in autism spectrum disorders.

Alabdali A, Al-Ayadhi L, El-Ansary A.

J Neuroinflammation. 2014 Jan 8;11:4. doi: 10.1186/1742-2094-11-4.

19.

Changes in plasticity across the lifespan: cause of disease and target for intervention.

Oberman L, Pascual-Leone A.

Prog Brain Res. 2013;207:91-120. doi: 10.1016/B978-0-444-63327-9.00016-3. Review.

20.

Use of transcranial magnetic stimulation in autism spectrum disorders.

Oberman LM, Rotenberg A, Pascual-Leone A.

J Autism Dev Disord. 2015 Feb;45(2):524-36. doi: 10.1007/s10803-013-1960-2. Review.

Items per page

Supplemental Content

Write to the Help Desk